| Aug 4, 2014
| 9:11 PM
There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
| Aug 5, 2014
| 9:30 PM
Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
| Jul 29, 2014
| 10:20 AM
Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals.
The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
| Sep 15, 2014
| 7:08 AM
Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health.
Internal records examined by Reuters reveal that some of the nation's largest poultry producers...
| Sep 8, 2014
| 12:06 PM
The Federal Trade Commission has filed suit against North Chicago-based AbbVie and a partner, alleging the companies illegally blocked consumer access to generic versions of the testosterone replacement drug AndroGel in order to reap hundreds of...
| Apr 11, 2014
| 10:30 PM
Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than HIV.
In a series of clinical trial results, a new...
| Apr 8, 2014
| 6:48 PM
A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos.
The jury in Lafayette,...
| Mar 21, 2014
| 1:46 PM
On Tuesday, the U.S. Supreme Court is slated to hear 90 minutes of oral arguments in a case that will determine whether bosses who have religious objections to birth control can deny their female employees the contraceptive coverage to which they are...
| Jan 2, 2014
| 2:20 PM
T. Rowe Price closed two funds focused on smaller companies to new investors Thursday, a move the firm said was designed to protect the traditionally risky funds from their own success.
The assets of the roughly $15.5 billion New Horizons Fund, which...
| Apr 30, 2014
| 2:30 AM
Kiplinger's Personal Finance
Working past 66 may not be everyone's idea of a dream "retirement," but for many baby-boomers, it could represent the future. A 2013 Wells Fargo survey showed that one-third of respondents expect to work until "at least 80"...
| Feb 12, 2014
| 8:33 PM
Nova Southeastern University is expanding its role in research, building a new $80 million facility that could boost South Florida's efforts to become a hub for studies of cancer, heart disease and other problems.
The Center for Collaborative Research,...